Re: RVXOT

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Telepanel

Rank: Treasurer [?]

Points: 1140 [?]

Votes: 22 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: RVXOT

in response to

Re: RVXOT

RVXoldtimer

posted on May 06, 2020 01:36PM

Makes you wonder wether they are trying to confuse investors.This looks like a "Shell" company to me

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply